418-P: Certain Patient Subgroups with Type 2 Diabetes May Benefit from Intensive Glycemic and Blood Pressure Control from Reductions in Major Adverse Cardiovascular Events (MACE) : A Machine Learning–Based Post Hoc Analysis of ACCORD Trial Data